| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
family with sequence similarity 234 member A | 1.000 | 0.077 | 1.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
tubulin tyrosine ligase like 11 | 0.931 | 0.077 | 6.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
otoraplin | 0.805 | 0.154 | 4.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
PDZ domain containing ring finger 4 | 0.805 | 0.269 | 9.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
hemoglobin subunit beta | 0.494 | 0.808 | 1.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 26 | 0.711 | 0.308 | 3.6E-24 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
aspartyl-tRNA synthetase 1 | 0.711 | 0.500 | 8.5E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
stearoyl-CoA desaturase 5 | 0.682 | 0.654 | 1.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 1475 | 0.780 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
atypical chemokine receptor 1 (Duffy blood group) | 0.608 | 0.731 | 2.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | |||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2016 | 2018 | ||||||||
|
diacylglycerol lipase beta | 0.931 | 0.154 | 2.6E-12 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | ||||||||
|
EH domain containing 4 | 0.931 | 0.115 | 4.2E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 598 | 0.743 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | |||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||
|
KDEL endoplasmic reticulum protein retention receptor 2 | 0.839 | 0.192 | 0.17 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | ||||||||
|
endosulfine alpha | 0.760 | 0.308 | 0.35 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | ||||||||
|
WW domain binding protein 1 like | 0.769 | 0.462 | 0.64 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
terminal nucleotidyltransferase 5C | 0.805 | 0.269 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
crystallin beta-gamma domain containing 2 | 9.7E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |